A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Dominika Olesova, Jaroslav Galba, Juraj Piestansky, Hana Celusakova, Gabriela Repiska, Katarina Babinska, Daniela Ostatnikova, Stanislav Katina, Andrej Kovac
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2020-11-01
Serija:	Metabolites
Teme:	autism spectrum disorder liquid chromatography mass spectrometry metabolomics oxidative stress gut microbiota
Online dostop:	https://www.mdpi.com/2218-1989/10/11/443
Oznake:	Označite Brez oznak, prvi označite!